124562-27-2

Upstream product

• 124581-08-4 (4S,5R)-2,2,3-Trimethyl-5-((E)-pent-3-enyl)-oxazolidine-4-carboxylic acid 
• 81135-30-0 L-2-aminobutyryl-sarcosyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanine benzyl ester 
• 104324-14-3 (2S,3R,6E)-3-hydroxy-2-(methylamino)-6-octenoic acid 
• 121741-84-2 (3'E,4R,5R)-4-(hydroxymethyl)-3-methyl-5-(3'-pentenyl)-2-oxazolidinone 
• 124562-09-0 (2S,3R,6E)-2,3-epoxy-1-<(N-methylcarbamoyl)oxy>-6-octene 
• 108536-06-7 (4S,5R)-3-methyl-5-<(3E)-pentenyl>-1-oxo-2-oxazolidine-4-carboxylic acid 

Downstream Products

• 124562-29-4 <(2S,3R,6E)-3-hydroxy-2-(methylamino)-6-octenoyl>-L-2-aminobutyryl-sarcosyl-N-methyl-L-leucyl-L-valyl-N-methyl-L-leucyl-L-alanine benzyl ester 

Relevant academic research and scientific papers

Synthesis, Conformation, and Immunosuppressive Activities of Three Analogues of Cyclosporin A Modified in the 1-Position

The syntheses of three new cyclosporin A (CsA) analogues that contain novel MeBmt derivatives in the 1-position are described.The MeBmt analogue that contains an additional methyl group on C4, (2S,3R,6E)-4,4-dimethyl-3-hydroxy-2-(N-methylamino)-6-octenoic